SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037605
Filing Date
2023-08-03
Accepted
2023-08-03 08:01:12
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgta-20230630.htm   iXBRL 10-Q 2137289
2 EX-31.1 mgta-ex31_1.htm EX-31.1 15920
3 EX-32.1 mgta-ex32_1.htm EX-32.1 12070
  Complete submission text file 0000950170-23-037605.txt   7172639

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgta-20230630.xsd EX-101.SCH 45551
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgta-20230630_pre.xml EX-101.PRE 326282
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgta-20230630_def.xml EX-101.DEF 279962
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgta-20230630_cal.xml EX-101.CAL 33070
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgta-20230630_lab.xml EX-101.LAB 380228
53 EXTRACTED XBRL INSTANCE DOCUMENT mgta-20230630_htm.xml XML 1164518
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 231138156
SIC: 2834 Pharmaceutical Preparations